Related Experiment Video
Updated: Jan 19, 2026

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
Published on: February 27, 2014
Diagnostic Challenges in the Early Onset of Inflammatory Bowel Disease: A Case Report
Naghi Dara1, Sharam Nemati2, Sharam Teimourian3
1Pediatric Gastroenterology, Hepatology and Nutrition Research Center, Research Institute for Children's Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Insights
Early genetic screening is crucial for diagnosing very early-onset inflammatory bowel disease (IBD) in infants. Identifying novel mutations, like the one in IL-12RB1, enables prompt diagnosis and targeted therapy for better outcomes.
Area of Science:
- Pediatric Gastroenterology
- Human Genetics
- Molecular Biology
Background:
- Very early-onset inflammatory bowel disease (IBD) (<6 years) presents diagnostic challenges due to diverse genetic defects and overlapping phenotypes.
- Current diagnostic strategies often struggle to identify specific molecular pathologies, leading to empirical treatment approaches.
- High morbidity and mortality underscore the need for precise diagnostic methods in infantile IBD.
Observation:
- A 7-month-old boy from a consanguineous marriage exhibited severe gastrointestinal disorders resembling IBD.
- Conventional IBD therapy for five months failed to achieve clinical remission.
- The patient ultimately died at 14 months of age.
Findings:
- A novel homozygous exonic variant (c.684C>T p(=)) in exon 7 of the IL-12RB1 gene was identified.
- In silico analysis suggested this mutation impacts the gene's splicing process.
- This genetic finding provides a molecular explanation for the patient's severe, treatment-refractory IBD-like condition.
Implications:
- Genetic screening should be considered an essential early diagnostic tool for infantile (<2 years) IBD.
- Early identification of specific genetic defects can facilitate prompt diagnosis.
- Targeted therapies based on precise molecular diagnoses hold promise for improving outcomes in pediatric IBD.
Abstract:
Inflammatory bowel disease (IBD) with very early onset manifestations (younger than six years of age) is an essential pediatric gastrointestinal disease that encompasses a group of diverse and rare genetic defects. It may be associated with chronicity, premalignant nature, and high morbidity and mortality during childhood. Because of overlapping phenotypes, the definitive diagnosis based on conventional strategies is frequently a challenge. However, many patients with different molecular pathologies are treated with the same therapeutic strategy. In this context, it is essential to define a more reliable method to provide an opportunity for a rapid and accurate diagnosis. Here we report a novel homozygous exonic variant in a patient with an IBD-like lesion in the colon during the infancy period. A 7 months old boy who was born of a consanguineous marriage developed gastrointestinal disorders early in life. After complete diagnostic workups, this case underwent conventional therapy of IBD for five months; but clinical remission was not achieved. We identified a novel homozygous mutation (c.684C>T p(=)) in exon 7 of IL-12RB1 gene that in silico studies indicated its significance in the splicing process. At the 14th month of age, this case died. Our finding reveals the importance of genetic screening as an early diagnostic tool in the identification of the underlying causes of IBD with very early onset manifestations, particularly infantile (< 2 years of age) IBD. This strategy makes an opportunity in prompt diagnosis and targeted therapy.
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
09:04DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...